Stay updated on Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial
Sign up to get notified when there's something new on the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page.

Latest updates to the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.6%
- Check22 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.SummaryDifference2%
- Check29 days agoChange DetectedThe web page has been updated to a new version, v2.16.0, replacing the previous version v2.15.2.SummaryDifference0.9%
- Check36 days agoChange DetectedDifference0.3%
- Check43 days agoChange DetectedDifference0.5%
Stay in the know with updates to Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page.